OpenBioMed is an agent platform and toolkit collection for biomedical research and drug discovery, covering areas such as molecular design, protein analysis, and single-cell data analysis. It is intended for researchers and provides the biomedical skills listed in the catalogue as workflows for Claude Code.
Getting it into your agent
One page per mod, every tool's command on it. A separate URL per tool would split the same page into five that compete with each other.
npx skills add PharMolix/OpenBioMed --skill target-based-lead-designgit clone --depth 1 https://github.com/PharMolix/OpenBioMedWrote this? Show the measurements
A badge with what this costs and how it scanned, read live from this page, so it follows the numbers instead of freezing them. Markdown for a README, HTML for a documentation site or a project page.
[](https://agentmods.dev/skills/pharmolix/openbiomed/target-based-lead-design)<a href="https://agentmods.dev/skills/pharmolix/openbiomed/target-based-lead-design"><img src="https://agentmods.dev/badge/skills/pharmolix/openbiomed/target-based-lead-design/github.svg" alt="Measured on agentmods" height="20"></a>Or the 80×15 button, for a site that already has a row of RSS and ATOM ones. Only the verdict fits; the numbers stay here.
<a href="https://agentmods.dev/skills/pharmolix/openbiomed/target-based-lead-design"><img src="https://agentmods.dev/badge/skills/pharmolix/openbiomed/target-based-lead-design.svg" alt="Reviewed on agentmods" width="80" height="20"></a>- NVIDIA SkillSpector warn
SkillSpector: 1 finding, up to medium
These are SkillSpector’s own severities. On a checked sample its high-severity flags on skills were ~96% false positives — a documented command, a public API, a “never do X” rule — so we show them as a caution to read, not a verdict. Why →
- medium analysis-evasion · line 1 Suspicious Unicode normalization or mixed-script contentFix: Review the flagged content for security risks. Ensure no credentials, secrets, or sensitive data are exposed.
What it costs to keep this loaded
Counted locally with the o200k_base tokenizer, which is exact for GPT models; Claude uses its own tokenizer and its counts differ. Treat this as one consistent yardstick across the catalogue rather than a bill. Prices are per million input tokens.
| Model | Per session | Once invoked |
|---|---|---|
| Fable 5.1 | $0.00099 | $0.03754 |
| Opus 5 | $0.00049 | $0.01877 |
| Sonnet 5 | $0.00020 | $0.00751 |
| Haiku 4.5 | $0.00010 | $0.00375 |
Grade A, and why
target-based-lead-design scanned grade A with 0 findings against 26 rules in 11 categories — prompt injection, anti-refusal, data exfiltration, privilege escalation, supply chain, agent snooping, system-prompt leakage, SSRF and excessive agency — measured 11d ago.
A static scan of the body, not an audit. Every finding is printed with the line that produced it so you can judge whether it matters here. A mod is markdown that instructs an agent; that is exactly why what it instructs is worth reading.
Nothing flagged
None of the 26 patterns this scan looks for appear in this file: no shell pipes, no recursive deletes, no credential paths, no hidden text, no instruction-override or anti-refusal phrasing, no agent-config snooping. That is not a guarantee, it is the absence of the things that are checkable.
How it starts
The opening of the file, as written. The whole thing — 434 lines — stays where its author put it; the contents beside it link to each section on GitHub.
Target-Based Lead Design
Generate diverse, drug-like lead compounds targeting a specific protein using AI-powered structure-based drug design.
When to Use
- User provides a PDB ID or disease name and wants drug candidates
- User wants to design molecules for a specific protein target
- User needs diverse leads with user-defined property criteria
- User wants iterative refinement with regeneration loop
Inputs
| Parameter | Type | Required | Description |
|---|---|---|---|
target |
str | Yes | PDB ID (e.g., "4xli") or disease name |
num_candidates |
int | No | Initial candidates to generate (default: 40) |
target_leads |
int | No | Desired number of final leads (default: 20) |
User Criteria (Filtering Thresholds)
| Criterion | Default | Description |
|---|---|---|
docking_threshold |
-10.0 | Maximum docking score (kcal/mol), more negative = better |
qed_min |
0.4 | Minimum QED score (0-1), higher = more drug-like |
lipinski_min |
4 | Minimum Lipinski rules obeyed (0-4), 4 = no violations |
side_effects_max |
18 | Maximum SIDER side effect categories predicted |
similarity_max |
0.7 | Maximum Tanimoto similarity between selected leads |
Workflow
Phase 1: Target Identification
└── Path A: PDB ID provided → Download structure directly
└── Path B: Disease/target name provided → Agent-based discovery:
├── Agent searches web for PDB structures
├── Agent examines each PDB's ligands
├── Agent searches literature to validate ligand is a true binder
│ └── Fallback (if 3 search attempts fail):
│ └── Judge by molecular weight:
│ • MW ≥ 150 Da → Likely drug-like binder (accept)
│ • MW 100-150 Da → Fragment (accept with caution)
│ • MW < 100 Da → Likely solvent/ion (exclude)
├── Agent ranks by resolution, returns best PDB ID
└── If no valid PDB found → Ask user for PDB ID
Phase 2: Structure Preparation
└── Extract protein chains and ligands
└── Define binding pocket (from reference ligand)
Phase 3: De Novo Generation
└── Generate candidates using MolCraft
└── Save candidates to SDF files
Phase 4: Docking
└── Dock all candidates (AutoDock Vina)
Phase 5: Property + ADMET Calculation
└── Drug-likeness: QED, SA, LogP, Lipinski
└── ADMET: BBB penetration, Side effects (SIDER)
Phase 6: Filtering & Diversity Selection
└── Apply user criteria → Filter candidates
└── Greedy diversity selection (Tanimoto)
└── Regeneration check → Iterate if needed
Phase 7: PLIP Interaction Analysis (selected molecules only)
└── Analyze protein-ligand interactions for selected leads
└── Report hydrophobic contacts, H-bonds, π-stacking, salt bridges
Phase 8: Visualization (selected molecules only)
└── 2D molecule structures (RDKit)
└── 3D rotating complex GIF (PyMOL, requires installation)
What ships with it
3 files beside SKILL.md in the same directory: the scripts, references and assets a skill reads on demand. Not counted in the per-session cost; read them before you install if any of them is executable.
What this file has done since we first saw it
Hashed on every crawl. A supply-chain change to an agent config is a question of when, not whether, so the history is kept rather than the latest state alone.
- 11d ago First seen · 434 lines · 99 tokens per session scan A 16df6e5e3102
target-based-lead-design is a skill published in the GitHub repository PharMolix/OpenBioMed (1,106 stars, last pushed 1mo ago), licensed MIT. It adds 99 tokens to every session and 3,754 once invoked, about $0.0005 per session on Opus 5. A static security scan graded it A with 0 findings. No closer match exists in the catalogue, so it is treated as the original; first seen 2026-08-30.
Other skills, from other repositories
deepchem
Molecular ML with diverse featurizers and pre-built datasets. Use for property prediction (ADMET, toxicity) with traditional ML or GNNs when you want extensive featurization options and MoleculeNet benchmarks. Best for quick experiments with pre-trained models, diverse molecular representations. For graph-first…
molecular-optimization
Iterative lead optimization with analyze-reason-generate-verify-evaluate loop. Paper-backed (MT-Mol, DrugR, MultiMol).
admet-reasoning
Interpretable ADMET analysis with mechanistic reasoning. Maps liabilities to structural causes and biological pathways. Based on CoTox (Park 2025) and DrugR (Liu 2026).
pocket-detection
Multi-method binding pocket detection and druggability assessment. Grid-based, fpocket, and P2Rank detection with druggability scoring, visualization, and cross-structure comparison.
structure-based-drug-design
Reasoning skill for structure-based drug design strategy. Use when the user asks to assess target druggability, choose a docking strategy, select a scoring function, define a binding site, interpret docking results, plan molecular dynamics or free energy perturbation (FEP), design a virtual screening cascade, or…
admet-prediction
ADMET (Absorption, Distribution, Metabolism, Excretion, Toxicity) prediction for drug candidates. Use for assessing drug-likeness, PK properties, and safety risks early in drug discovery. Keywords: ADMET, PK, toxicity, drug-likeness, DILI, hERG, bioavailability.